Pharmaceutical discount agreement for Oralair
Original notice title
Germany – Pharmaceutical products – Abschluss nicht exkl. Arzneimittel-Rabattvereinb. nach § 130a Abs. 8 SGB V im Wege eines Open-House-Modells über Arzneimittel mit dem Handelsnamen Oralair(R) (ATC-Code nach WHO: V01AA02)
Opportunity Score
Why this score?
Opportunity
43 / 100
Complexity
67 / 100
Risk factors
The authority expressly states that demand and purchase quantities are unknown and that minimum quantities are not guar...
The authority may terminate the open-house procedure early, particularly after exclusive rebate agreements are conclude...
Deep Portfolio Analysis
Uses:
- Description
- Industries & Services
- Capabilities
- Market & Experience
- Certifications
Tender facts
- Contracting authority
- AOK PLUS - Die Gesundheitskasse für Sachsen und Thürigen
- Country
- Germany
- CPV
- 33600000 - Pharmaceutical products
- Deadline
- Aug 31, 2028
Overview
Moderate opportunityKey Facts
- Supplies contract
- 1 lot
- Duration until Aug 2028
- Conclusion of non-exclusive pharmaceutical rebate agreements under § 130a(8) SGB V for Oralair (ATC V01AA02).
- Scope includes corresponding parallel imports and re-imports.
Show full summary
Open-house framework-style pharmaceutical rebate arrangement for Oralair (ATC V01AA02), including parallel and re-imported products, offered by AOK PLUS in Germany. Participation is open to eligible pharmaceutical entrepreneurs meeting the stated conditions, without negotiations or exclusivity. Demand and purchases are not guaranteed, rebate terms are contained in restricted participation documents, and the procedure may end early if exclusive agreements are concluded.
Risks
The authority expressly states that demand and purchase quantities are unknown and that minimum quantities are not guar...
The authority may terminate the open-house procedure early, particularly after exclusive rebate agreements are conclude...
Analysis may be incomplete
Only part of the procurement documentation was analyzed. Additional eligibility requirements, certificates, or submission documents may exist in the remaining tender documentation.
Key Requirements
Technical
- Participation is limited to pharmaceutical entrepreneurs within the meaning of § 4(18) AMG in relation to the offered medicinal products.
- The participant must accept the fixed open-house contractual conditions; individual contract negotiations are not conducted.
Eligibility
- An executed declaration confirming the absence of mandatory and optional exclusion grounds under §§ 123 and 124 GWB is required.
Buyer
Location
Dresden, DEU
Website
Buyer profile
Identifier
DE256878834
Activity
Health
Lots (1)
LOT-0001
Oralair Pharmaceutical Rebate Agreement
Non-exclusive rebate agreement under § 130a(8) SGB V for Oralair (ATC V01AA02), including parallel and re-imported products, under an open-house model. No minimum purchase quantity is guaranteed. The lot information is based on structured tender data and the XML notice.
Location
Duration
Category
Deadline
Award details
Siehe Kurzbeschreibung
Show original TED data
Original lot title
Abschluss nicht exkl. Arzneimittel-Rabattvereinb. nach § 130a Abs. 8 SGB V im Wege eines Open-House-Modells über Arzneimittel mit dem Handelsnamen Oralair(R) (ATC-Code nach WHO: V01AA02)
Original TED description
Siehe Kurzbeschreibung
Procurement Details
- Publication date
- 09 Jul 2026
- Languages
- German
Reference metadata
- Legal basis
- 32014L0024
Reference IDs
- Tender ID
- 477144-2026
Documents (1)
Similar tenders
Poland – Pharmaceutical products – produkty lecznicze w 309 pakietach dla potrzeb Apteki Szpitalnej Wojewódzkiego Szpitala Zespolonego w Elblągu
Poland – Pharmaceutical products – „Dostawa płynów infuzyjnych, roztworów leczniczych oraz produktów do żywienia dojelitowego i pozajelitowego”
Sweden – Pharmaceutical products – Apoteksprodukter
Poland – Pharmaceutical products – Zakup i dostawa leków
Poland – Pharmaceutical products – Dostawa produktów farmaceutycznych i dietetycznych
Norway – Pharmaceutical products – Medicines and multi-dose Narvik kommune - Framework agreement
Opportunity Score
Why this score?
Opportunity
43 / 100
Complexity
67 / 100
Risk factors
The authority expressly states that demand and purchase quantities are unknown and that minimum quantities are not guar...
The authority may terminate the open-house procedure early, particularly after exclusive rebate agreements are conclude...
Deep Portfolio Analysis
Uses:
- Description
- Industries & Services
- Capabilities
- Market & Experience
- Certifications